Capital International, Inc./CA/

Position in AMGN — Amgen Inc

CIK 895213 Los Angeles, CA

Position in AMGN

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$108,550,901

-$31,509,676 QoQ

Shares Held

299,765

-24.7% QoQ

Ownership

0.055%

of shares outstanding

% of Portfolio

0.77%

of 13F equity value

Holder Rank

#140

of 3,149 holders

Holding Since

Sep 2021

12 quarters on record

Voting authority Sole 36% Shared 0% None 64%

Healthcare · as of Jun 30, 2026

Capital International, Inc./CA/ holds $998,315,428 across 11 Drug Manufacturers - General names. AMGN ranks #4 (10.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	1,949,177	$369,602,942
2	LLY	ELI LILLY & Co	198,681	$238,303,971
3	ABBV	AbbVie Inc.	435,569	$109,606,583
4	AMGN	Amgen Inc This page	299,765	$108,550,901
5	MRK	Merck & Co., Inc.	454,397	$58,390,014
6	GILD	Gilead Sciences, Inc.	363,947	$45,981,063
7	JNJ	Johnson & Johnson	178,793	$45,408,058
8	PFE	Pfizer Inc	376,556	$9,067,468

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$108,550,901	299,765	-24.7%	Shares	Defined	2026-08-12
2026-03-31	$140,060,577	398,069	-6.4%	Shares	Defined	2026-05-13
2025-12-31	$139,274,660	425,513	+10.0%	Shares	Defined	2026-02-11
2025-09-30	$109,150,444	386,784	+22.8%	Shares	Defined	2025-11-13
2025-06-30	$87,916,527	314,876	+37.3%	Shares	Defined	2025-08-13
2025-03-31	$71,446,203	229,325	+37.1%	Shares	Defined	2025-05-12
2024-12-31	$43,595,688	167,264	+52.2%	Shares	Defined	2025-02-13
2024-09-30	$35,416,356	109,917	+1.1%	Shares	Defined	2024-11-13
2024-06-30	$33,983,311	108,764	+8.5%	Shares	Defined	2024-08-13
2024-03-31	$28,500,521	100,241	+1749.5%	Shares	Defined	2024-05-14
2021-12-31	$1,219,337	5,420	0.0%	Shares	Defined	2022-02-14
2021-09-30	$1,152,563	5,420	—	Shares	Defined	2021-11-15
No filing history on record for this holder in this stock.